YLJ-27781-58781 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-31
Dose 1 — Pfizer-BioNTech
2021-04-23
Registered in v-safe
2021-04-23
Dose 2 — Pfizer-BioNTech
2021-04-23
Health check-in — day 0, dose 2
Feeling: Fair · None

Adult check-in
2021-04-24
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Joint pains, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-04-25
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-04-26
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-04-27
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-28
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-29
Survey response — days 1–6 daily, dose 2
MedDRA: Chills, Headache, Injection site pain — Feeling: Good

Free text: After first injection, sharp periodic headache pain. That went away with the second injection. With second injection after first day, I experienced swollen sore tongue, possibly swollen glands along my jaw line, and occasional ear ache. Today, my nasal cavity had a slight burning sensation. All of these symptoms could be explained away with other causes and so I didnt connect them with the vaccine.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-30
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-05-07
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-05-14
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-05-21
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-05-28
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-06-04
Survey response — day 42, dose 2
MedDRA: Heavy exposure to ultraviolet light, Rash erythematous — Feeling: Good

Free text: Extreme rash to sun exposure

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-26
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2022-04-23
Survey response — 12 months, dose 2
MedDRA: Paraesthesia, Urinary incontinence — Feeling: Fair · Be unable to do your normal daily activities

Free text: Tingling feet Loss of bladder control

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-31	Pfizer-BioNTech
2	2021-04-23	Pfizer-BioNTech

Free text

Release 8 — days 1–6 daily, dose 2

2021-04-29

Systemic reaction (other): After first injection, sharp periodic headache pain. That went away with the second injection. With second injection after first day, I experienced swollen sore tongue, possibly swollen glands along my jaw line, and occasional ear ache. Today, my nasal cavity had a slight burning sensation. All of these symptoms could be explained away with other causes and so I didnt connect them with the vaccine.

Release 8 — day 42, dose 2

2021-06-04

Symptoms: Extreme rash to sun exposure

Release 11 — 12 months, dose 2

2022-04-23

Symptoms: Tingling feet Loss of bladder control

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Heavy exposure to ultraviolet light	✓	✓	✓
SD	Paraesthesia	·	·	✓
SD	Rash erythematous	✓	✓	✓
SD	Urinary incontinence	·	·	✓
SRO	Chills	✓	✓	✓
SRO	Headache	✓	✓	✓
SRO	Injection site pain	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release